Eosinophilia myalgia syndrome: I. Immunocytochemical evidence for a T‐cell–mediated immune effector response

Annals of Neurology

Volumn 29, Issue 5, 1991, Pages 524-528

  Emslie‐Smith, Alison M ^a   Engel, Andrew G ^a   Duffy, Joseph ^a   Bowles, Carolyn A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRYPTOPHAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EOSINOPHILIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MYALGIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; AGED; ANTIGENS, CD; COMPLEMENT MEMBRANE ATTACK COMPLEX; EOSINOPHILIA; FASCIA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNITY, CELLULAR; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIDDLE AGE; MUSCLES; MUSCULAR DISEASES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SYNDROME; T-LYMPHOCYTES;

EID: 0025847313     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410290512     Document Type: Article

References (16)

1. Eosinophilia‐myalgia syndrome–New Mexico
2. Interim guidance on the eosinophilia‐myalgia syndrome (editorial)
3. Eosinophilia myalgia syndrome associated with L‐Tryptophan ingestion: clinical features and aspects of pathophysiology
4. Association of L‐Tryptophan and an illness resembling eosinophilic fasciitis: clinical and histopathologic findings in four patients with eosinophilia‐myalgia syndrome
5. Eosinophilia myalgia syndrome due to L‐Tryptophan ingestion: report of four cases and review of the Maryland experience
6. An investigation of the eosinophilia‐myalgia syndrome associated with Tryptophan use
7. Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigenspecific cell‐mediated cytotoxicity in some diseases and implications for the pathogenesis of the different inflammatory myopathies
8. Mononuclear antibody analysis of mononuclear cells in myopathies: I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells
9. Microvascular changes in early and advanced dermatomyositis: a quantitative study
10. Neoantigen of the polymerized ninth component of complement characterization of a monoclonal antibody and immunohistochemical localization in renal disease
11. Variations in CD4 expression by human monocytes and macrophages and their relationship to infection with the human immunodeficiency virus
12. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell‐mediated cytotoxicity in myopathies
13. Effects of tumor necrosis factor and related cytokines on vascular endothelial cells
14. Regulation of HLA class I and class II antigen expression
15. 5‐hydroxytryptamine and tryptamine pathways in scleroderma
16. Development of a scleroderma‐like illness during therapy with L‐5‐hydroxytryptophan and carbidopa